A case of fulminant myocarditis associated with a novel coronavirus infection

Abstract

Background COVID-19 patients mainly have the high incidence and mortality of major cardiovascular diseases in the acute phase. However, fulminant myocarditis and cardiogenic shock are rare in the post-acute phase, and the prognosis is very poor. Case presentation Here, we report a case of a 43-year-old young man with fulminant myocarditis and cardiogenic shock in the acute phase after coronavirus infection, with timely extracorporeal membrane oxygenation and intra-aortic balloon application in respiratory failure, which improved the prognosis of fulminant myocarditis and saved the lives of COVID-19 patients. After active anti-shock, mechanical ventilation, anti-inflammation, and organ support and other treatments, the patient was discharged after a stable condition and stable vital signs. The patient was followed up weekly after discharge and showed good cardiopulmonary recovery. Conclusions In critically ill patients with severe myocarditis, cardiogenic shock, arrhythmia, respiratory and circulatory failure, ECMO and IABP in patients with explosive myocardial inflammatory cardiogenic shock have achieved better results.